PRECIGEN, INC.

PGEN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.5B · 47 employees
227
SEC Filings
$4.51
Close 2026-05-28
47
Employees

Business Summary

PART I Overview We are a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients. We are leveraging our proprietary technology platforms to develop product candidates designed to target urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. We believe that our array of technology platforms uniquely positions us among other biotechnology c...

Latest Stock Quote

PGEN 2026-05-28 $4.51 O:$4.51 H:$4.6795 L:$4.35 Vol:5.7M VWAP:$4.4713
origin leaf: 3cda0144a639a71657630b963288651f521056e70a5000eee020cc861c82606a

Next Earnings

Q2 FY2026 — expected 2026-09-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001356090-26-000009EDGAR81K words
2025-03-192024-12-310001356090-25-000007EDGAR—
2024-03-192023-12-310001356090-24-000007EDGAR—
2023-03-062022-12-310001356090-23-000004EDGAR—
2022-03-012021-12-310001356090-22-000002EDGAR—
2021-03-012020-12-310001356090-21-000003EDGAR—
2020-03-022019-12-310001628280-20-002699EDGAR—
2019-03-012018-12-310001356090-19-000004EDGAR—
2018-03-012017-12-310001356090-18-000002EDGAR—
2017-03-012016-12-310001356090-17-000003EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001356090-25-000034EDGAR27K words
2025-08-122025-06-300001356090-25-000024EDGAR—
2025-05-142025-03-310001356090-25-000019EDGAR—
2024-11-142024-09-300001356090-24-000026EDGAR—
2024-08-142024-06-300001356090-24-000017EDGAR—
2024-05-142024-03-310001356090-24-000010EDGAR—
2023-11-092023-09-300001356090-23-000017EDGAR—
2023-08-092023-06-300001356090-23-000013EDGAR—
2023-05-102023-03-310001356090-23-000009EDGAR—
2022-11-092022-09-300001356090-22-000013EDGAR—
2022-08-082022-06-300001356090-22-000009EDGAR—
2022-05-092022-03-310001356090-22-000006EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250000950103-26-004648EDGAR3K words
2025-11-130000950103-25-014683EDGAR—
2025-09-170000950103-25-011775EDGAR—
2025-09-030001104659-25-086669EDGAR—
2025-08-180000950103-25-010408EDGAR—
2025-08-180001104659-25-079497EDGAR—
2025-06-300000950103-25-008124EDGAR—
2025-05-140000950103-25-006004EDGAR—
2025-03-190000950103-25-003637EDGAR—
2025-01-160000950103-25-000576EDGAR—

227 total filings indexed. 195 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001356090
TickerPGEN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedVA
Websitehttp://www.precigen.com
Listed2013-08-08

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c522fe2855657b92ec7907e9d3c41d7fd4123ab657978759b6b2692adf2eb3d2
parent: 00640e6db92905f2a4188cdbdbf17b86a2bb09d759fb51e79fe745c53af35964
content hash: 793148fa2cf71373b4774c4483e39744901d6c58f3e3e0019b12daed4fd428af
signed: 2026-06-03T12:02:14.102Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf